Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
about
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinomaVirus-induced hepatocellular carcinoma with special emphasis on HBV.C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.Human viruses and cancer.MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.Downregulation of mPGES-1 Expression via EGR1 Plays an Important Role in Inhibition of Caffeine on PGE2 Synthesis of HBx(+) Hepatocytes.Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response.Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular CarcinomaActivation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cellsGene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA.Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progressionSystemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lungLncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA mannermicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7.Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma.Epigenetic Dysregulation in Virus-Associated Neoplasms.Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein.Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.SULF1/SULF2 reactivation during liver damage and tumour growth.Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis.Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma.MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas.Multi-omics in prognosis of hepatocellular carcinoma.Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3.Splenic diffuse red-pulp small B-cell lymphoma associated with hepatitis B virus: a report of two cases.Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells.DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis.Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma.Beneficial effects of naringenin in liver diseases: Molecular mechanisms.Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.Molecular mechanisms of the preventable causes of cancer in the United States
P2860
Q28069313-71B3D0E0-0E0C-439B-8176-1C2A35213760Q30238961-4A268334-F54A-4AE5-AF8D-798055FE7168Q33618740-20969A6A-D2EA-4AE0-9723-A4B4515BAC6BQ33689008-03F9FB69-47BF-4A8A-931B-5C5F1351FEE0Q33765935-B001A074-D2C7-47AA-AA82-0755AC2A9892Q33899640-33B0A84B-33AE-44C1-844F-05ABA8186BA8Q34423461-ACB90E98-1085-4762-8FAB-389F16828AB3Q35925686-80E606D3-B58E-4D38-A5BB-2D42D9CB2462Q36204556-47E082D1-7A14-41E8-8F78-B36133F3BD1EQ36269684-849E59B8-CACD-47B1-A332-AAE975CD0927Q36414519-F0EC14F2-5FE5-4A18-BB31-59CBB4B0F577Q36666935-7B615D20-95EB-408C-B365-749706DAB8ACQ36859970-22CB1F3E-2A3C-4500-8BA2-A69884BC83C8Q36946700-BCFD67E4-0067-428E-B6BD-5F368EA5A5B7Q36965734-F92D0043-7748-428D-8866-2A1D21C0374EQ37224290-C82FD2E9-291D-4628-936E-2469CE4B1ACCQ37390759-FE1688CF-251D-4D62-AC91-8D0D41E69C9BQ37634229-DDBD7E31-5CCF-47B5-AB29-170A8E93EE8CQ37714431-4896B253-A947-468C-BCEC-1918DF34DA53Q38408925-4160B6AF-3018-4CC7-A1CF-17A63DF05C41Q38545840-5484C786-8EFC-4246-A0AA-EF78632C0B92Q38667127-51DA8489-4DF3-4787-9804-E8567115D7CEQ38695501-B8D6513D-3341-4E71-AA11-758A49F0D0FAQ38723615-4C230050-1CFC-4AC6-AAE0-2AA3CB317207Q38783242-D452BB7F-CDC9-4E50-96C0-C5A1956C59E4Q38986144-F3C5DBB5-973D-4502-B01F-8352FA23ADEAQ39253341-7AB43093-CF86-4289-A4D1-BC3A18BD99EDQ40107680-5899799C-459C-4523-94A7-AB71B9DAAE80Q40684744-E298C2C2-A96F-4CC7-B821-9F2AA6209105Q40767105-2CCEE2B2-7288-40A3-AA06-39EAEFB7932CQ41813489-1A29C879-6265-49A9-AE75-8AAE685D16C5Q43105015-BDAD43AC-890D-4B51-8EBB-45842D443BCBQ45324907-14384709-5A82-4C66-9F6A-516C09B37BF6Q45333583-5224CA55-8FA6-488A-B698-147C589382B5Q47131939-5BEB4A02-5BBE-40C2-9A7E-86B680C6DA8CQ50042001-F1C341B1-B8F0-480E-A3F4-A9C0E94BF03AQ52614628-0C7C15CD-98E0-4138-9150-DF2A543216EFQ54113356-DBB21AC0-0324-48CF-A247-6030D48E33FCQ55044828-022C8EB8-1ABE-43C5-806C-9ED021832EF0Q56475873-D1D12F5E-F65F-44AB-A0D3-DBCD8A885752
P2860
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@ast
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@en
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@nl
type
label
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@ast
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@en
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@nl
prefLabel
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@ast
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@en
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@nl
P2860
P50
P3181
P1476
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
@en
P2093
Mirko Tarocchi
P2860
P304
11630-11640
P3181
P356
10.3748/WJG.V20.I33.11630
P407
P577
2014-09-07T00:00:00Z